MANUFACTURING ARTICLES

MANUFACTURING VIDEOS

Join our webinar on scaling the CTS LV-MAX System in bioreactors, covering transfection scalability, Thermo S.U.B. advantages, and DynaSpin’s efficient gene therapy integration.

Three regulatory experts share the topics on which they hope to see further agency clarification in the near-term to help mRNA products make meaningful progress toward/through the clinic.

We share our experience working with organizations as they adopt solutions for automated data acquisition, aggregation, visualizations, and statistical analysis.

Is enzymatic ligation a futuristic dream or a current commercial reality? In this segment, industry experts Claire McCleod and Jill Caswell explore how the sector has moved past the proof-of-concept stage into early commercialization and what this looks like/means for early adopters today. 

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS